Role of chemokines and their receptors in cancer

Related Experiment Video

Updated: Jun 19, 2026

In vitro Cell Migration and Invasion Assays
09:55

In vitro Cell Migration and Invasion Assays

Published on: June 1, 2014

Roeliene C Kruizinga1, Jovanka Bestebroer, Paul Berghuis

  • 1Department of Medical Oncology, University Medical Center Groningen and University of Groningen, 9700 RB Groningen, The Netherlands.

Current Pharmaceutical Design
|October 29, 2009
PubMed

Insights

Metastasis, the spread of cancer, drives 90% of cancer deaths. Targeting chemokines, which facilitate cancer cell invasion and tumor growth, offers a promising new therapeutic strategy beyond traditional DNA-damaging treatments.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Metastasis is responsible for 90% of cancer fatalities, representing a significant failure of current treatments like chemotherapy and radiotherapy.
  • Cancer cell invasion and metastasis are fundamental neoplastic features, not merely consequences of DNA damage.
  • Metastasis is an organized, multi-step process influenced by specific organ environments.

Purpose of the Study:

  • To investigate the role of chemokines in cancer cell metastasis.
  • To explore how chemokines influence tumor progression, angiogenesis, and immune responses.
  • To identify potential therapeutic targets within chemokine pathways for cancer treatment.

Main Methods:

  • Utilized in vitro and in vivo models to study tumor cell behavior.
  • Analyzed chemokine-mediated mechanisms in cancer cell invasion and trafficking.
  • Examined the impact of chemokines on tumor angiogenesis and host immune modulation.

Main Results:

  • Tumor cells employ chemokine-mediated mechanisms for metastasis, similar to leukocyte trafficking.
  • Chemokines regulate tumor-associated angiogenesis and stimulate tumor cell proliferation autocrinely.
  • Chemokines also modulate host anti-tumor immunological responses.

Conclusions:

  • Chemokines play a critical role in multiple facets of cancer progression and metastasis.
  • Targeting chemokines or their receptors presents a novel therapeutic avenue for cancer treatment.
  • These targeted therapies could significantly improve outcomes for cancer patients.

More Related Videos

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Related Concept Videos

Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...